| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
1998-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b779845ce09e468fc8d500b23f2b99 |
| publicationDate |
1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9927932-A1 |
| titleOfInvention |
Injectable antifungal formulations |
| abstract |
A pharmaceutical composition suitable for parenteral administration comprising an antifungally effective amount of a compound represented by formula (I), wherein X is independently both F or both Cl or one X is independently F and the other is independently Cl; R1 is a straight or branched chain (C4-C5) alkyl group substituted by a hydroxy moiety; and an effective amount of maltosyl-β-cyclodextrin or glucosyl-β-cyclodextrin, is disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117951-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208500-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10633462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10851184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6989381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10040872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800861-B2 |
| priorityDate |
1997-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |